Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-88.39	52.22	449.94
Graham Fair Price	104.25	25.96	12.71
PEG	-92.09	-0.04	0.45
Price/Book	11.87	8.22	7.35
Price/Cash Flow	-59.95	148.85	-371.67
Prices/Earnings	-69.07	17.42	-56.31
Price/Sales	11.19	20.99	18.88
Price/FCF	-59.95	148.85	-371.67
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-2.67	0.75	0.77
Operating Margin	1731.35	0.37	-0.02
ROA	291.45	0.04	-0.01
ROE	-0.03	0.12	261.64
ROIC	< 0.005	0.07	2616.91
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.06	0.04	39.77
Dividends QOQ	< 0.005	0.05	130075.97
EBIT QOQ	-1.05	20.79	1880.22
EPS QOQ	-1.26	4.92	291.24
FCF QOQ	-1.11	4.00	260.68
Revenue QOQ	-0.08	0.08	-3.43
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	171.32	148.89	-13.09
Days Sales Outstanding (DSO)	68.11	71.57	5.08
Inventory Turnover	0.53	0.60	15.06
Debt/Capitalization	0.48	0.46	-5.33
Quick Ratio	0.71	0.73	2.65
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	14.84	15.94	7.41
Cash	2.83	2.25	-20.25
Capex	-0.39	-0.34	12.94
Free Cash Flow	-0.29	0.88	200.00
Revenue	5.78	6.24	8.06
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.25	1.25	0.07
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	43.24	4.14	-90.43
Naive Interpretation	Member

06 - Financial Health · Weak

Rating